Tacrolimus Eye Drops for Anterior Uveitis
(EYETAC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The primary objective of the study is to investigate the safety and tolerability of NOV05 eye drops at two concentrations QID in patients with active non-infectious anterior uveitis.
Who Is on the Research Team?
Sonja Kroesser, PhD
Principal Investigator
Novaliq GmbH
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Tacrolimus Ophthalmic Solution
How Is the Trial Designed?
2
Treatment groups
Active Control
Find a Clinic Near You
Who Is Running the Clinical Trial?
Novaliq GmbH
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.